CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.
Li D, Hu W, Lin X, Zhang J, He Z, Zhong S, Wen X, Zhang P, Jiang X, Duan H, Guo C, Wang J, Zeng J, Chen Z, Mou Y, Sai K.
Li D, et al. Among authors: jiang x.
Front Cell Dev Biol. 2021 Mar 19;9:653240. doi: 10.3389/fcell.2021.653240. eCollection 2021.
Front Cell Dev Biol. 2021.
PMID: 33796538
Free PMC article.